In the News

Our work, in the news.

The latest news, milestones, and recognition from across PhaseWell Research.

Press Release
September 2026

Community Clinical Research Joins PhaseWell Research to Anchor Inpatient CNS Capabilities and Expand Clinical Trial Access Across Austin and Broader Texas Region

The partnership establishes Community Clinical Research as the foundation of PhaseWell’s inpatient neuropsychiatric research capabilities, deepening the company’s CNS therapeutic pillar and extending its national reach into one of the country’s fastest growing and most diverse research markets.

Read the Release
Press Release
September 2026

The Gabrail Cancer Center Undertakes Investigator-Initiated Study Evaluating the T-Cell Engager Elranatamab in Combination with Starton Therapeutics’ Controlled Low-Dose Lenalidomide

Trial led by Nashat Gabrail, M.D., will assess dose-finding, safety and preliminary efficacy of STAR-LLD alongside elranatamab in relapsed or refractory multiple myeloma

Read the Release
Press Release
June 2026

Latin Clinical Trial Center joins PhaseWell Research to Expand Clinical Trial Access and Therapeutic Reach in Puerto Rico

The partnership brings Puerto Rico’s premier clinical research site into PhaseWell’s national network, deepening capabilities in cardiometabolic disease and broadening reach across immunology, pulmonary, infectious disease, and autoimmune indications.

Read the Release
Press Release
March 2026

PhaseWell Research Acquires Chase Medical Research to Expand Clinical Trial Capabilities in Connecticut

The acquisition expands PhaseWell’s Northeast footprint and advances its ability to support cardiometabolic and central nervous system (CNS) clinical research within the community.

Read the Release
Press Release
January 2026

Bio Behavioral Health Joins PhaseWell Research to Expand Access to Neuropsychiatric Clinical Trials

The Bio Behavioral Health acquisition strengthens PhaseWell’s national footprint and advances community-based research in central nervous system (CNS) therapeutic areas.

Read the Release
Press Release
August 2025

The Formation of PhaseWell Research

PhaseWell combines deep therapeutic expertise with trusted local investigators to expand access to advanced clinical trials.

Read the Release

For media inquiries, contact BD@phasewell.com